En español
NIDA

NIDA Notes Articles: HIV or AIDS

NIDA Notes Category Graphic

New Approach Uses Immune Cells To Deliver Anti-HIV Medications

October 2014
Nano-antiretroviral therapy (nano-ART) turns macrophages—one of the very cell types that HIV uses to replicate and spread through the body—into carriers for anti-HIV medications. The approach has the potential to make treatment for HIV easier and more effective.

NIDA Notes Category Graphic

NIDA Recognizes Developer of a New Business Model for Science

November 2011
Dr. Redonna K. Chandler of NIDA receives the Institute's 2011 Innovator Award for developing a method that fosters collaboration and data sharing on various studies of HIV in criminal justice populations.

NIDA Notes Category Graphic

NIDA's 35th Anniversary: Science Focused on Solutions

December 2009
Commemorates NIDA’s 35th anniversary and highlights some of the major accomplishments since the Institute’s inception in 1974.

NIDA Notes Category Graphic

NIDA's National Advisory Council Welcomes New Members

October 2006
Introduces four new members to NIDA’s National Advisory Council on Drug Abuse, including Drs. Warren K. Bickel, Ellie E. Schoenbaum, and Marina E. Wolf, and Ms. Janet Wood.

NIDA Notes Category Graphic

Prison Use of Medications for Opioid Addiction Remains Low

July 2011
Describes results from a nationwide survey among correctional facilities on the use of opioid replacement therapy for people who are addicted to heroin.

NIDA Notes Category Graphic

Research Addresses Needs of Criminal Justice Staff and Offenders

April 2009
Highlights a project in which nine research centers collaborate with criminal justice partners to test science-based tools for integrating drug abuse treatment in prisons and probation and parole programs.

NIDA Notes Category Graphic

Researchers Report on Progress of NIDA's Southern Africa Initiative

March 2008
Presents an update on NIDA’s Southern African Initiative, a program that aims to build research capacity and infrastructure in the area of addiction, particularly drug-related HIV transmission.

NIDA Notes Category Graphic

Seek-Test-Treat-Retain To Stop the Spread of HIV

February 2013
Despite the advances in treatment and prevention, roughly 50,000 new HIV infections still occur annually in the Nation. Research, in large part supported by NIDA, has produced a strategy to address this circumstance and break the epidemiological impasse: seek out HIV-infected individuals, particularly those in “hard-to-reach” groups that have minimal contact with the health care system; offer them HIV testing and treatment; and provide support to help them stay in treatment.

NIDA Notes Category Graphic

Selenium Shows Promise as an Adjunct Therapy for HIV

December 2008
Reports on a randomized controlled trial of HIV-infected men and women who, as a result of receiving selenium supplements, experienced lower HIV viral load and greater CD4 cell count.

NIDA Notes Category Graphic

Study Assesses Functional Deficits Due to HIV and Methamphetamine Use

November 2014
Methamphetamine use and HIV infection raise the risk for functional dependence, or the need for assistance with everyday tasks. People who use methamphetamine and are HIV positive showed the highest levels of functional dependence in most domains of daily life.

Pages

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics